Owens & Minor - OMI Stock Forecast, Price & News

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. It provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. The company was founded in 1882 and is headquartered in Richmond, Virginia.

Owens & Minor Stock Performance

NYSE:OMI traded up $1.33 during trading hours on Wednesday, reaching $34.60. 597,966 shares of the company's stock were exchanged, compared to its average volume of 784,337. Owens & Minor has a 1-year low of $29.50 and a 1-year high of $49.11. The firm has a market capitalization of $2.64 billion, a price-to-earnings ratio of 17.13, a P/E/G ratio of 1.32 and a beta of 0.55. The company has a quick ratio of 0.58, a current ratio of 1.55 and a debt-to-equity ratio of 2.68. The company has a 50-day moving average of $32.91 and a 200 day moving average of $37.82.

Owens & Minor (NYSE:OMI - Get Rating) last posted its quarterly earnings results on Wednesday, August 3rd. The company reported $0.76 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.76. Owens & Minor had a net margin of 1.56% and a return on equity of 26.66%. The firm had revenue of $2.50 billion during the quarter, compared to analysts' expectations of $2.53 billion. During the same period in the prior year, the company posted $1.06 earnings per share. The firm's revenue for the quarter was up .4% on a year-over-year basis. Research analysts anticipate that Owens & Minor will post 3.19 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on OMI. Credit Suisse Group lowered their target price on shares of Owens & Minor from $43.00 to $37.00 and set a "neutral" rating for the company in a report on Thursday, August 4th. Robert W. Baird lowered their target price on shares of Owens & Minor from $70.00 to $62.00 and set an "outperform" rating for the company in a report on Thursday, August 4th. StockNews.com cut shares of Owens & Minor from a "buy" rating to a "hold" rating in a research note on Wednesday, May 11th. Finally, Citigroup decreased their price target on shares of Owens & Minor from $58.00 to $52.00 in a research note on Thursday, August 4th. Two equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, Owens & Minor has a consensus rating of "Hold" and an average target price of $50.33.

Insiders Place Their Bets

In other Owens & Minor news, Director Gwendolyn M. Bingham sold 7,600 shares of the business's stock in a transaction that occurred on Thursday, May 12th. The stock was sold at an average price of $35.32, for a total transaction of $268,432.00. Following the transaction, the director now owns 22,184 shares in the company, valued at approximately $783,538.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Gwendolyn M. Bingham sold 7,600 shares of the company's stock in a transaction that occurred on Thursday, May 12th. The stock was sold at an average price of $35.32, for a total value of $268,432.00. Following the sale, the director now owns 22,184 shares in the company, valued at approximately $783,538.88. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, COO Jeffrey T. Jochims sold 8,000 shares of the company's stock in a transaction that occurred on Friday, July 1st. The stock was sold at an average price of $31.31, for a total value of $250,480.00. Following the completion of the sale, the chief operating officer now owns 195,956 shares in the company, valued at approximately $6,135,382.36. The disclosure for this sale can be found here. 4.09% of the stock is currently owned by insiders.